A variety of functioning GEP NETs are associated with MEN1, most frequently gastrinomas (in 40% of patients) or insulinomas (10%), less frequently VIPomas, somatostatinomas and glucagonomas [18]. Here, MEN1 is linked to gastrin-producing neuroendocrine tumor.